# Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit

> **NCT05282004** · PHASE3 · COMPLETED · sponsor: **Sandoz** · enrollment: 36 (actual)

## Conditions studied

- Neovascular Age-related Macular Degeneration (nAMD)

## Interventions

- **DRUG:** SOK583A1

## Key facts

- **NCT ID:** NCT05282004
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-16
- **Primary completion:** 2022-09-07
- **Final completion:** 2022-09-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282004, "Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05282004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*